قارن الطرق
راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.
| بطارية التقييم الجبهي× | مقياس تقييم مرض الزهايمر - المعرفي× | |
|---|---|---|
| المجال | علم النفس العصبي | علم النفس العصبي |
| العائلة | Process / pipeline | Process / pipeline |
| سنة النشأة≠ | 2000 | 1984 |
| صاحب الطريقة≠ | Bruno Dubois | William Rosen |
| النوع≠ | Clinician-administered neuropsychological battery for frontal lobe function | Clinician-administered cognitive scale for Alzheimer's disease |
| المصدر التأسيسي≠ | Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626. DOI ↗ | Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364. DOI ↗ |
| الأسماء البديلة≠ | FAB, Frontal Battery | ADAS-Cog, ADAS-Cog14, ADAS-Cog13 |
| ذات صلة | 5 | 5 |
| الملخص≠ | The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function. | The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months. |
| ScholarGateمجموعة البيانات ↗ |
|
|